Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
Science (New York, N.Y.), Volume 329, Issue 5996, 2010, Pages 1168-1174.
viral loadincidencenucleotidesepidemiologyyoung adultMore(4+)
The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of tenofovir, a nucleotide reverse transcriptase inhibitor, for the prevention of HIV acquisition in women. A double-blind, randomized controlled trial was conducted comparing tenofovir gel ...More
Full Text (Upload PDF)